SELL and acute myeloid leukemia: We obtained 11 potential surface markers significantly upregulated in the FA predicted_AML cells including CD200, CD99, CD74, HLA-DR/DP/DQ, CXCR4, LAIR1, L-Selectin, P-Selectin, Galectin-9 and PECAM-1 (Fig 4A), previously reported by others authors as surface markers in different cell types [50–60] or even to identify leukemic cells [50,52,55,61–64].